Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Total Long Term Debt (Quarterly): 0.00 for Sept. 30, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
--
Maximum
Mar 2022
--
Average
--
Median
Mar 2022
Total Long Term Debt (Quarterly) Benchmarks
Johnson & Johnson | 41.49B |
Axonics Inc | 0.00 |
Harpoon Therapeutics Inc (DELISTED) | 0.00 |
Merck & Co Inc | 37.79B |
RayzeBio inc (DELISTED) | -- |